Wong went on to induce evolutionary changes in bacterial strains. He slowly weaned Bacillus subtilis, a common soil bacterium, on to 4-fluorotryptophan (4FTrp) and off canonical tryptophan in a strain called HR23.
In their recent work, Yu et al. (2014) wanted to know how this genetic leap had been possible. However, simply comparing the genomes of HR23 and wild-type B. subtilis would have presented a confusing picture.
"You'll see random genetic changes that may have nothing to do with the [new] phenotype," says Chan. "The beauty of the study is that Jeffrey [Wong] did keep all these intermediate strains and allowed us to sequence them so that we would know what happened as a gradual process." The researchers also sequenced and compared a HR23 precursor strain able to use both Trp and 4FTrp as well as a later strain of HR23 that regained the ability to use Trp.
They found a suite of differences, ranging from genes related to Trp metabolism and stress response to mutations in the transcription and translation machinery. "Wong's original paper is a landmark in my mind," says Jamie Bacher, a CEO of a biotech company in the San Francisco Bay Area. "It opened up a lot of questions and opportunity. Seeing the follow-up, seeing those original strains sequenced and compared is creative and exciting."
He believes that the team's findings may be practically relevant as well as theoretically interesting.
"I think there is the potential for this to be industrially applied," Bacher says. "For example, they noted that one of the first mutations in the precursor strain was in the mtrB gene, a negative regulator of Trp transport."
Likely, mtrB opens up the transport of tryptophan in all forms, he says. "So if you're going to optimize an industrial strain of bacteria to incorporate an unnatural amino acid, this kind of knockout mutation might be something you want to do early on." Highlights editor: George Jianzhi Zhang
